Alprot综合征基因突变对Ⅳ型胶原结构及功能的影响
结题报告
批准号:
39970775
项目类别:
面上项目
资助金额:
13.0 万元
负责人:
丁洁
依托单位:
学科分类:
H0501.泌尿系统结构、功能与发育异常
结题年份:
2002
批准年份:
1999
项目状态:
已结题
项目参与者:
姚勇、张英、张敬京、俞礼霞
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
在明确了Alport综合征(AS)基因突变的基础上,拟进一步用原位、Northern杂交和免疫荧光学方法,从肾脏和皮肤组成的mRNA和蛋白表达水平检测并分析Ⅳ胶原6个α链之一的α5链基因COL4A5突变后,α5及其它α链在转录和翻译水平的变化和异常,期望由此为进一步进行基因治疗在Ⅳ型胶原的分子组成特性和功能改变方面提供一定的依据。
英文摘要
The study aimed to explore the influence of post-mutations in COL4A5 gene on the structure and function of a5(IV) chain, which will help to understand the pathogenesis of Alport syndrome (AS), and further to benefit the future work of gene therapy. The strategy of this study was to detect and analyze the a5(IV) chain transcripted and translated from the mutation COL4A5 gene of AS patient. Total RNA was isolated from the cultured fibroblast obtained from skin biopsy. The whole length of a5(IV) chain coding region was amplified by 5 cDNA fragments with RT-PCR. The cDNA fragment was detected and checked via electrophoresis first and then sequencing. Any fragment with mutation would be further analyzed and confirmed by the sequences of relevant genomic DNA fragment (usually exon plus partial flank intronic sequences). The main achievements included, (1) Many novel mutations of COL4A5 gene were detected in Chinese AS kindreds. The results revealed that the mutation gene did not "turn-off" its transcription and, analysis of cDNA of fibroblasts instead of genomic DNA is a efficient (with a detection rate of 90%), convenient and economic way to diagnose COL4A5gene mutations. (2) AS with mutations of both COL4A5 and COL4A6 was firstly diagnosed in Chinese population. Those kind of patients presented with or without leomyomatosis will depend on different mutations in COL4A6 gene. (3) It is the first time in China that the heterozygous status in AS females was demonstrated by analyzing COL4A5 gene and the expression of the mutated gene. The segmental distribution of a5(Ⅳ) chain in basement membranes, the mild clinical symptoms and the better prognosis in AS females would belong to the heterozygous COL4A5 gene. (4) For the first time in China, a COL4A5 gene mutation was detected in an X-linked AS boy with normal expressions of a3-5 (IV) chains in epidermal and glomerular basement membranes. The result has been published in several national and international academic medical journals, including the journal of Pediatric Nephrology authorized by International Pediatric Nephrology Association, and also communicated widely during scientific congress.
专著列表
科研奖励列表
会议论文列表
专利列表
Ⅳ型胶原疾病Alport综合的早期肾眼耳器官特异性发病机制和多学科管理的中德合作研究
  • 批准号:
    --
  • 项目类别:
    国际(地区)合作与交流项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    丁洁
  • 依托单位:
钙调神经磷酸酶在肾病足细胞损伤中的作用及分子调节机制
  • 批准号:
    81570640
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2015
  • 负责人:
    丁洁
  • 依托单位:
足细胞中补体系统活化以及在足细胞损伤中作用机制研究
  • 批准号:
    81170657
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2011
  • 负责人:
    丁洁
  • 依托单位:
蛋白尿时肾小球足细胞"重塑"的作用分子及分子机制研究
  • 批准号:
    30830105
  • 项目类别:
    重点项目
  • 资助金额:
    185.0万元
  • 批准年份:
    2008
  • 负责人:
    丁洁
  • 依托单位:
抗蛋白尿药物在足细胞作用的分子机制探讨
  • 批准号:
    30672259
  • 项目类别:
    面上项目
  • 资助金额:
    28.0万元
  • 批准年份:
    2006
  • 负责人:
    丁洁
  • 依托单位:
Alport综合征异常α5(IV)链蛋白的结构特征及功能分析
  • 批准号:
    30371495
  • 项目类别:
    面上项目
  • 资助金额:
    21.0万元
  • 批准年份:
    2003
  • 负责人:
    丁洁
  • 依托单位:
裂孔隔膜及足突细胞骨架分子在蛋白尿产生中的作用
  • 批准号:
    30170992
  • 项目类别:
    面上项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2001
  • 负责人:
    丁洁
  • 依托单位:
汉族Alport综合征COL4A5基因突变及其表型相关性研究
  • 批准号:
    39770780
  • 项目类别:
    面上项目
  • 资助金额:
    12.0万元
  • 批准年份:
    1997
  • 负责人:
    丁洁
  • 依托单位:
国内基金
海外基金